IJICHI Nobuhiro 伊地知暢広

Researcher Number	80380624
Other IDs
External Links
Affiliation (based on the past Project Information) *help	2015 – 2023: 鹿児島大学, 医歯学域医学系, 助教 2012 – 2014: 鹿児島大学, 医歯(薬)学総合研究科, 助教 2012: 鹿児島大学, 大学院・医歯学総合研究科, 助教 2010 – 2011: 埼玉医科大学, 医学部, 研究員
Review Section/Research Field	Principal Investigator Basic Section 56020:Orthopedics-related / Orthopaedic surgery / Tumor therapeutics / Clinical oncology / Endocrinology Except Principal Investigator Basic Section 52050:Embryonic medicine and pediatrics-related / Medium-sized Section 52:General internal medicine and related fields / Orthopaedic surgery / Circulatory organs internal medicine / Experimental pathology / Pediatrics
Keywords	Principal Investigator 骨軟部腫瘍 / 腫瘍溶解性ウイルス / がん免疫 / 免疫遺伝子ウイルス治療 / 骨・軟部腫瘍学 / 骨・軟部腫瘍 / 遺伝子・ウイルス治療 / がん免疫遺伝子・ウイルス治療 / 遺伝子治療 / アデノウイルス … More / 癌幹細胞 / がん遺伝子治療 / タモキシフェン耐性 / Erα / FOXA1 / 次世代シーケンサー / FOXP1 / エストロゲン / 乳がん / 内分泌療法 / エストロゲン関連受容体 / 核内受容体 / 間葉系細胞分化 / iPS細胞 / 遺伝子 / 発生・分化 / 再生医学 … More Except Principal Investigator 腫瘍溶解性ウイルス / 免疫学 / 遺伝子 / ウイルス / 癌 / 再生医学 / がん免疫治療 / 免疫治療 / 癌免疫治療 / CAR-T / ヒトES/iPS細胞 / 再生医療 / 心筋細胞 / アデノウイルスベクター / ヒトiPS細胞 / ヒトES細胞 / ES細胞 / 腫瘍化 / サバイビン / ウイルスベクター / 遺伝子治療 / iPS細胞 / 幹細胞 / 小児腫瘍学 Less

多面的な抗腫瘍免疫誘導をもたらす革新的ながん免疫ウイルス併用療法の開発Principal Investigator
- Principal Investigator
  
  伊地知暢広
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56020:Orthopedics-related
- Research Institution
  Kagoshima University
Generation of Innovative Cancer Immune Gene and Cell Therapy Technology by Replicating Virus and CAR-T
- Principal Investigator
  
  Kosai Ken-ichiro
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 52:General internal medicine and related fields
- Research Institution
  Kagoshima University
a
- Principal Investigator
  
  Kosai Ken-ichiro
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Kagoshima University
Development of innovative immunovirotherapy facilitating anti-tumor immunity in bone and soft tissue tumorsPrincipal Investigator
- Principal Investigator
  
  Ijichi Nobuhiro
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56020:Orthopedics-related
- Research Institution
  Kagoshima University
Development of Innovative Gene-Virus Therapy for Tumor Lysis, Immunity Induction, and Cancer Stem Cell Suppression in Bone and Soft Tissue Sarcoma.
- Principal Investigator
  
  Kosai Ken-ichiro
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Orthopaedic surgery
- Research Institution
  Kagoshima University
Development of the novel oncolytic immuno-virotherapy for bone and soft tissue tumorsPrincipal Investigator
- Principal Investigator
  
  IJICHI NOBUHIRO
- Project Period (FY)
  2016 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Orthopaedic surgery
- Research Institution
  Kagoshima University
Molecular elucidation of normal and cancer stem cells towards development of innovative m-CRA therapy for pediatric cancer
- Principal Investigator
  
  Ken-ichiro Kosai
- Project Period (FY)
  2013 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Pediatrics
- Research Institution
  Kagoshima University
Development of the novel vector system targeting and identifying cancer stem cells for innovative cancer therapyPrincipal Investigator
- Principal Investigator
  
  Ijichi Nobhiro
- Project Period (FY)
  2013 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Kagoshima University
The development of the novel vector that eliminates ES/iPS cell-derived tumor to realize regenerative medicine
- Principal Investigator
  
  Kosai Ken-ichiro
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Experimental pathology
- Research Institution
  Kagoshima University
Identificationof novel diagnostic and therapeutic factors for endocrine therapy-resistant breast cancer by next-generation sequencing strategyPrincipal Investigator
- Principal Investigator
  
  IJICHI Nobuhiro
- Project Period (FY)
  2012
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Clinical oncology
- Research Institution
  Kagoshima University
A novel method for identification and isolation of human pluripotent stem cell-derived target cells and elimination of tumorigenic cells.
- Principal Investigator
  
  Mitsui Kaoru
- Project Period (FY)
  2012 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Circulatory organs internal medicine
- Research Institution
  Kagoshima University
Evaluation of functional roles of estrogen related receptors(ERRs) on differentiation of mesenchymal-derived cells using induced pluripotent stem cells.Principal Investigator
- Principal Investigator
  
  IJICHI Nobuhiro
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Endocrinology
- Research Institution
  Saitama Medical University

All 2022 2020 2018 2017 2016 2013 2012 2011 2010 Other

All Journal Article Presentation Book Patent

[Book] 次世代がん治療研究最前線2017
- Author(s)
  伊地知暢広、小戝健一郎
- Publisher
  株式会社エヌ・ティー・エス
- Data Source
  KAKENHI-PROJECT-25430153
[Book] 次世代がん治療第3編ウイルスを用いたがん治療第3章ウイルス治療薬開発『独自開発の多因子増殖制御型アデノウイルス（m-CRA）技術による遺伝子・ウイルス治療薬の臨床開発と実用化の展望』2017
- Author(s)
  伊地知暢広、小戝健一郎
- Total Pages
  347
- Publisher
  エヌ・ティー・エス
- ISBN
  9784860435035
- Data Source
  KAKENHI-PROJECT-16K10869
[Book] Adipocytes : Biology, Regulation and Health Impact2012
- Author(s)
  Nobuhiro Ijichi
- Total Pages
  9
- Publisher
  Nova Science Publishers, Inc.
- Data Source
  KAKENHI-PROJECT-22790888
[Book] Roles of Estrogen-Related Receptors in Adipocyte Differentiation. Adipocytes : Biology, Regulation and Health Impact2012
- Author(s)
  Ijichi N, Ikeda K, Horie-Inoue K, Inoue S
- Publisher
  New York : Nova Science Publishers(At press)
- Data Source
  KAKENHI-PROJECT-22790888
[Book] HORMONES AND BREAST CANCER, Elsevier
- Author(s)
  Ijichi N, Ikeda K, Horie-Inoue K, Inoue S
- Publisher
  (in press)
- Data Source
  KAKENHI-PROJECT-24701033
[Journal Article] A Novel Construction of Lentiviral Vectors for Eliminating Tumorigenic Cells from Pluripotent Stem Cells.2018
- Author(s)
  Ide K, Mitsui K, Irie R, Matsushita Y, Ijichi N, Toyodome S, Kosai KI.
- Journal Title
  
  Stem Cells
  
  Volume: 36 Issue: 2 Pages: 230-239
- DOI
  10.1002/stem.2725
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10869, KAKENHI-PROJECT-15K19389, KAKENHI-PROJECT-26860813, KAKENHI-PROJECT-18K07851, KAKENHI-PROJECT-18K15853
[Journal Article] A Novel Construction of Lentiviral Vectors for Eliminating Tumorigenic Cells from Pluripotent Stem Cell2018
- Author(s)
  Ide K, Mitsui K, Irie R, Matsushita Y, Ijichi N, Toyodome S, Kosai K
- Journal Title
  
  Stem Cells
  
  Volume: 36 Pages: 230-239
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04315
[Journal Article] A Novel Construction of Lentiviral Vectors for Eliminating Tumorigenic Cells from Pluripotent Stem Cell.2018
- Author(s)
  Ide K, Mitsui K, Irie R, Matsushita Y, Ijichi N, Toyodome S, Kosai K
- Journal Title
  
  Stem Cells.
  
  Volume: 36 Pages: 230-239
- Data Source
  KAKENHI-PROJECT-17H04315
[Journal Article] Association of positive EBAG9 immunoreactivity with unfavorable prognosis in breast cancer patients treated with tamoxifen.2013
- Author(s)
  Ijichi N, Shigekawa T, Ikeda K, Miyazaki T, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki S, Saeki T, Inoue S
- Journal Title
  
  Clin Breast Cancer
  
  Volume: 13 Issue: 6 Pages: 465-470
- DOI
  10.1016/j.clbc.2013.08.015
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23249040, KAKENHI-PUBLICLY-24116521, KAKENHI-PROJECT-25430153
[Journal Article] FOXP1 and Estrogen Signaling in Breast Cancer2013
- Author(s)
  Ijichi N, Ikeda K, Horie-Inoue K, Inoue S
- Journal Title
  
  Vitamins & Hormones Hormones and Breast Cancer
  
  Volume: 93 Pages: 203-212
- DOI
  10.1016/b978-0-12-416673-8.00006-x
- ISBN
  9780124166738
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25430153
[Journal Article] Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients2012
- Author(s)
  Ijichi N, Shigekawa T, Ikeda K,Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S
- Journal Title
  
  Horm Cancer
  
  Volume: 3 Issue: 4 Pages: 147-159
- DOI
  10.1007/s12672-012-0111-0
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591016, KAKENHI-PROJECT-22790888, KAKENHI-PROJECT-23249040, KAKENHI-PROJECT-23659479, KAKENHI-PROJECT-24701033
[Journal Article] Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells2012
- Author(s)
  Abe Y, Ijichi N, Ikeda K, Kayano H, Horie-Inoue K, Takeda S, Inoue S
- Journal Title
  
  Cancer Sci
  
  Volume: 103 Pages: 806-812
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790888
[Journal Article] FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer2011
- Author(s)
  Shigekawa T, Ijichi N, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S
- Journal Title
  
  Horm Cancer
  
  Volume: 2 Pages: 286-297
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790888
[Journal Article] Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer2011
- Author(s)
  伊地知暢広
- Journal Title
  
  The Journal of steroid biochemistry and molecular biology
  
  Volume: 123(1-2) Pages: 1-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790888
[Patent] 安全を確保しながら転移性がんまで効果的に治療可能な、搭載する免疫誘導遺伝子の最適発現レベルを与える発現制御システムを有する腫瘍溶解性ウイルス(腫瘍溶解性免疫治療)2020
- Inventor(s)
  小戝健一郎、伊地知暢広
- Industrial Property Rights Holder
  鹿児島大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2019-552379
- Filing Date
  2020
- Data Source
  KAKENHI-PROJECT-20K21580
[Patent] 安全を確保しながら転移性がんまで効果的に治療可能な、搭載する免疫誘導遺伝子の最適発現レベルを与える発現制御システムを有する腫瘍溶解性ウイルス(腫瘍溶解性免疫治療)2020
- Inventor(s)
  小戝健一郎、伊地知暢広
- Industrial Property Rights Holder
  鹿児島大学
- Industrial Property Rights Type
  特許
- Filing Date
  2020
- Overseas
- Data Source
  KAKENHI-PROJECT-20K21580
[Patent] 安全を確保しながら転移性がんまで効果的に治療可能な、搭載する免疫誘導遺伝子の最適発現レベルを与える発現制御システムを有する腫瘍溶解性ウイルス(腫瘍溶解性免疫治療)2020
- Inventor(s)
  小戝健一郎、伊地知暢広
- Industrial Property Rights Holder
  鹿児島大学
- Industrial Property Rights Type
  特許
- Filing Date
  2020
- Overseas
- Data Source
  KAKENHI-PROJECT-20H03645
[Patent] 安全を確保しながら転移性がんまで効果的に治療可能な、搭載する免疫誘導遺伝子の最適発現レベルを与える発現制御システムを有する腫瘍溶解性ウイルス(腫瘍溶解性免疫治療)2020
- Inventor(s)
  小戝健一郎、伊地知暢広
- Industrial Property Rights Holder
  鹿児島大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2019-552379
- Filing Date
  2020
- Data Source
  KAKENHI-PROJECT-20H03645
[Patent] 安全を確保しながら転移性がんまで効果的に治療可能な、搭載する免疫誘導遺伝子の最適発現レベルを与える発現制御システムを有する腫瘍溶解性ウイルス(腫瘍溶解性免疫治療)2020
- Inventor(s)
  小戝健一郎、伊地知暢広
- Industrial Property Rights Holder
  鹿児島大学
- Industrial Property Rights Type
  特許
- Filing Date
  2020
- Overseas
- Data Source
  KAKENHI-PROJECT-20H03645
[Patent] 安全を確保しながら転移性がんまで効果的に治療可能な、搭載する免疫誘導遺伝子の最適発現レベルを与える発現制御システムを有する腫瘍溶解性ウイルス(腫瘍溶解性免疫治療)2020
- Inventor(s)
  小戝健一郎、伊地知暢広
- Industrial Property Rights Holder
  鹿児島大学
- Industrial Property Rights Type
  特許
- Filing Date
  2020
- Overseas
- Data Source
  KAKENHI-PROJECT-20K21580
[Patent] 安全を確保しながら転移性がんまで効果的に治療可能な、搭載する免疫誘導遺伝子の最適発現レベルを与える発現制御システムを有する腫瘍溶解性ウイルス(腫瘍溶解性免疫治療)2020
- Inventor(s)
  小戝健一郎、伊地知暢広
- Industrial Property Rights Holder
  鹿児島大学
- Industrial Property Rights Type
  特許
- Filing Date
  2020
- Overseas
- Data Source
  KAKENHI-PROJECT-20H03645
[Patent] 安全を確保しながら転移性がんまで効果的に治療可能な、搭載する免疫誘導遺伝子の最適発現レベルを与える発現制御システムを有する腫瘍溶解性ウイルス(腫瘍溶解性免疫治療)2020
- Inventor(s)
  小戝健一郎、伊地知暢広
- Industrial Property Rights Holder
  鹿児島大学
- Industrial Property Rights Type
  特許
- Filing Date
  2020
- Overseas
- Data Source
  KAKENHI-PROJECT-20K21580
[Patent] 安全を確保しながら転移性がんまで効果的に治療可能な、搭載する免疫誘導遺伝子の最適発現レ　ベルを与える発現制御システムを有する腫瘍溶解性ウイルス（腫瘍溶解性免疫治療）2018
- Inventor(s)
  小戝健一郎、伊地知暢広
- Industrial Property Rights Holder
  小戝健一郎、伊地知暢広
- Industrial Property Rights Type
  特許
- Filing Date
  2018
- Overseas
- Data Source
  KAKENHI-PROJECT-17H04315
[Patent] 安全を確保しながら転移性がんまで効果的に治療可能な、搭載する免疫誘導遺伝子の最適発現レ　ベルを与える発現制御システムを有する腫瘍溶解性ウイルス（腫瘍溶解性免疫治療）2017
- Inventor(s)
  小戝健一郎、伊地知暢広
- Industrial Property Rights Holder
  小戝健一郎、伊地知暢広
- Industrial Property Rights Type
  特許
- Filing Date
  2017
- Data Source
  KAKENHI-PROJECT-17H04315
[Presentation] 鹿児島大学での COVID-19 下でのオンライン組織学実習への取り組み2022
- Author(s)
  三井薫、伊地知暢広、井手佳菜子、松田恵理子、小戝健一郎
- Organizer
  第127回日本解剖学会総会・全国学術集会
- Data Source
  KAKENHI-PROJECT-19K09653
[Presentation] Survivin-responsive Conditionally Replicating Adenovirus for Patients with Advanced Sarcoma Demonstrated Potent and Long-term Efficacy and High Safety in Phase 1 Clinical Trial.2020
- Author(s)
  Satoshi Nagano, Toshitaka Futagawa, Eriko Sumi, Nobuhiro Ijichi, Munekazu Yamakuchi, Masanori Nakajo, Teruto Hashiguchi, Yasuo Takeda, Takashi Yoshiura, Akira Shimizu, Muneo Takatani, Setsuro Komiya, Ken-ichiro Kosai.
- Organizer
  2020 ASCO Annual Meeting.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K21580
[Presentation] Survivin-responsive Conditionally Replicating Adenovirus for Patients with Advanced Sarcoma Demonstrated Potent and Longterm Efficacy and High Safety in Phase 1 Clinical Trial.2020
- Author(s)
  Satoshi Nagano, Toshitaka Futagawa, Eriko Sumi, Nobuhiro Ijichi, Munekazu Yamakuchi, Masanori Nakajo, Teruto Hashiguchi, Yasuo Takeda, Takashi Yoshiura, Akira Shimizu, Muneo Takatani, Setsuro Komiya, Ken-ichiro Kosai.
- Organizer
  2020 ASCO Annual Meeting.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20H03645
[Presentation] COVID-19下でのオンライン組織学実習への取り組み2020
- Author(s)
  三井薫、伊地知暢広、井手佳菜子、小戝健一郎
- Organizer
  日本解剖学会第76回九州支部学術集会
- Data Source
  KAKENHI-PROJECT-20K21580
[Presentation] 次世代の腫瘍溶解性ウイルスの開発と癌と再生医学への治療応用2020
- Author(s)
  西川路侑耶、伊地知暢広、三井薫、小戝健一郎
- Organizer
  日本解剖学会第76回九州支部学術集会
- Data Source
  KAKENHI-PROJECT-20K21580
[Presentation] 次世代の腫瘍溶解性ウイルスの開発と癌と再生医学への治療応用2020
- Author(s)
  西川路侑耶、伊地知暢広、三井薫、小戝健一郎
- Organizer
  日本解剖学会第76回九州支部学術集会
- Data Source
  KAKENHI-PROJECT-20H03645
[Presentation] Phase I Study of Potentially "Best-in-Class" Survivin-Responsive Conditionally Replicating Adenovirus for Advanced Sarcoma Actually Demonstrates Potent and Long-Term Efficacy and High Safety2018
- Author(s)
  Ken-ichiro Kosai, Satoshi Nagano, Toshitaka Futagawa, Eriko Sumi, Nobuhiro Ijichi, Munekazu Yamaguchi, Masanori Nakajo, Teruto Hashiguchi, Yasuo Takeda, Takashi Yoshiura, Akira Shimizu, Muneo Takatani, Setsuro Komiya
- Organizer
  AMERICAN SOCIETY of GENE & CELL THERAPY(21stAnnual Meething ASGCT )
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04315
[Presentation] Phase I Study of Potentially "Best-in-Class" Survivin-Responsive Conditionally Replicating Adenovirus for Advanced Sarcoma Actually Demonstrates Potent and Long-Term Efficacy and High Safety．2018
- Author(s)
  Ken-ichiro Kosai, Satoshi Nagano, Toshitaka Futagawa, Eriko Sumi, Nobuhiro Ijichi, Munekazu Yamaguchi, Masanori Nakajo, Teruto Hashiguchi, Yasuo Takeda, Takashi Yoshiura, Akira Shimizu, Muneo Takatani, Setsuro Komiya
- Organizer
  AMERICAN SOCIETY of GENE & CELL THERAPY
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04315
[Presentation] Phase I Study of Potentially "Best-in-Class" Survivin-Responsive Conditionally Replicating Adenovirus for Advanced Sarcoma Actually Demonstrates Potent and Long-Term Efficacy and High Safety2018
- Author(s)
  S.Nagano, T.Futagawa, E.Sumi, N.Ijichi, M.Yamaguchi, M.Nakajo, T.hashiguchi, Y.Takeda, T.Yoshiura, A.Shimizu, M.Takatani, S.Komiya, K-i.Kosai
- Organizer
  American Association for Cancer Research(AACR Annual Meeting)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04315
[Presentation] Development of next-generation oncolytic viro-immuno-therapy and investigator-initiated first-in-human clinical trial2018
- Author(s)
  Ken-ichiro Kosai, Satoshi Nagano, Nobuhiro Ijichi, Toshitaka Futagawa, Eriko Sumi, Munekazu Yamaguchi, Masanori Nakajo, Teruto Hashiguchi, Yasuo Takeda, Takashi Yoshiura, Akira Shimizu, Muneo Takatani, Setsuro Komiya
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17H04315
[Presentation] 独自開発の多因子制御によるがん特異的増殖型アデノウイルスの肝癌幹細胞への革新的治療作用2017
- Author(s)
  伊地知暢広、田上聖徳、小戝健一郎
- Organizer
  第16回日本再生医療学会総会
- Place of Presentation
  仙台国際センター（宮城県仙台市）
- Year and Date
  2017-03-07
- Data Source
  KAKENHI-PROJECT-25430153
[Presentation] 独自開発の多因子制御による癌特異的増殖型アデノウイルスの肝癌幹細胞への革新的治療作用O-28-1．（国内・口頭）2017
- Author(s)
  伊地知　暢広、田上　聖徳、小戝　健一郎
- Organizer
  第16回日本再生医療学会、2017年3月7-9日（宮城）
- Data Source
  KAKENHI-PROJECT-17H04315
[Presentation] 増殖制御型アデノウイルスによる癌・再生医学研究へのハムスターモデルの開発2017
- Author(s)
  伊地知暢広、川上広高、小宮節郎、小戝健一郎
- Organizer
  第122回日本解剖学会総会全国学術集会
- Place of Presentation
  長崎大学坂本キャンパス（長崎県長崎市）
- Year and Date
  2017-03-28
- Data Source
  KAKENHI-PROJECT-25430153
[Presentation] 遺伝子治療、再生医療の独自開発技術の臨床応用と発生学への展望2017
- Author(s)
  小戝健一郎、三井薫、井手佳菜子、伊地知暢広、入江理恵
- Organizer
  第122回日本解剖学会総会全国学術集会
- Place of Presentation
  長崎大学坂本キャンパス（長崎県長崎市）
- Year and Date
  2017-03-28
- Data Source
  KAKENHI-PROJECT-16K10869
[Presentation] 遺伝子治療、再生医療の独自開発技術の臨床応用と発生学への展望．（国内・シンポジウム）2017
- Author(s)
  小戝　健一郎、三井　薫、井手　佳菜子、伊地知　暢広、入江　理恵
- Organizer
  第122回日本解剖学会総会全国学術集会2017年3月28-30日（長崎）
- Data Source
  KAKENHI-PROJECT-17H04315
[Presentation] 独自開発の多因子制御によるがん特異的増殖型アデノウイルスの肝癌幹細胞への革新的治療作用2017
- Author(s)
  伊地知　暢広
- Organizer
  再生医療学会
- Place of Presentation
  仙台国際センター（宮城県仙台市）
- Year and Date
  2017-03-09
- Data Source
  KAKENHI-PROJECT-25293234
[Presentation] 遺伝子治療、再生医療の独自開発技術の臨床応用と発生学への展望2017
- Author(s)
  小戝健一郎、三井薫、井手佳菜子、伊地知暢広、入江理恵
- Organizer
  第122回日本解剖学会総会全国学術集会
- Place of Presentation
  長崎大学坂本キャンパス（長崎県長崎市）
- Year and Date
  2017-03-28
- Data Source
  KAKENHI-PROJECT-25430153
[Presentation] 独自開発の多因子制御によるがん特異的増殖型アデノウイルスの肝癌幹細胞への革新的治療作用2017
- Author(s)
  伊地知暢広、田上聖徳、小戝健一郎
- Organizer
  第16回日本再生医療学会総会
- Place of Presentation
  仙台国際センター（宮城県仙台市）
- Year and Date
  2017-03-07
- Data Source
  KAKENHI-PROJECT-16K10869
[Presentation] 増殖制御型アデノウイルスによる癌・再生医学研究へのハムスターモデルの開発2017
- Author(s)
  伊地知　暢広
- Organizer
  再生医療学会
- Place of Presentation
  長崎大学医学部（長崎県長崎市）
- Year and Date
  2017-03-28
- Data Source
  KAKENHI-PROJECT-25293234
[Presentation] 増殖制御型アデノウイルスによる癌・再生医学研究へのハムスターモデルの開発2017
- Author(s)
  伊地知暢広、川上広高、小宮節郎、小戝健一郎
- Organizer
  第122回日本解剖学会総会全国学術集会
- Place of Presentation
  長崎大学坂本キャンパス（長崎県長崎市）
- Year and Date
  2017-03-28
- Data Source
  KAKENHI-PROJECT-16K10869
[Presentation] サイトカイン遺伝子搭載腫瘍溶解性アデノウィルス（Surv.m-CRA）開発のための同種移植担癌ハムスターモデルの確立2016
- Author(s)
  川上広高，小濱祐行，伊地知暢弘，小戝健一郎
- Organizer
  第９回桜ヶ丘地区基礎系研究発表会
- Place of Presentation
  鶴陵会館（鹿児島県鹿児島市）
- Year and Date
  2016-02-08
- Data Source
  KAKENHI-PROJECT-25670194
[Presentation] 免疫活性化遺伝子（サイトカイン）を発現する腫瘍溶解性アデノウィルス（Surv.m-CRA）の開発2016
- Author(s)
  小濱祐行，川上広高，伊地知暢弘，小戝健一郎
- Organizer
  第９回桜ヶ丘地区基礎系研究発表会
- Place of Presentation
  鶴陵会館（鹿児島県鹿児島市）
- Year and Date
  2016-02-08
- Data Source
  KAKENHI-PROJECT-25293234
[Presentation] 免疫活性化遺伝子（サイトカイン）を発現する腫瘍溶解性アデノウィルス（Surv.m-CRA）の開発2016
- Author(s)
  小濱祐行，川上広高，伊地知暢弘，小戝健一郎
- Organizer
  第９回桜ヶ丘地区基礎系研究発表会
- Place of Presentation
  鶴陵会館（鹿児島県鹿児島市）
- Year and Date
  2016-02-08
- Data Source
  KAKENHI-PROJECT-25670194
[Presentation] サイトカイン遺伝子搭載腫瘍溶解性アデノウィルス（Surv.m-CRA）開発のための同種移植担癌ハムスターモデルの確立2016
- Author(s)
  川上広高，小濱祐行，伊地知暢弘，小戝健一郎
- Organizer
  第９回桜ヶ丘地区基礎系研究発表会
- Place of Presentation
  鶴陵会館（鹿児島県鹿児島市）
- Year and Date
  2016-02-08
- Data Source
  KAKENHI-PROJECT-25293234
[Presentation] フォークヘッド転写因子FOXP1の全ゲノムにおける結合部位同定によるERシグナル調節機構の解析2012
- Author(s)
  伊地知暢広
- Organizer
  第20回日本ステロイドホルモン学会学術集会
- Place of Presentation
  石川県金沢市
- Data Source
  KAKENHI-PROJECT-24701033
[Presentation] ER陽性乳癌におけるフォークヘッド転写因子FOXP1の役割2012
- Author(s)
  重川崇、伊地知暢広、池田和博、堀江公仁子、清水千佳子、佐治重衡、青儀健二郎、津田均、大崎昭彦、佐伯俊昭、井上聡
- Organizer
  第12回関東ホルモンと癌研究会
- Place of Presentation
  文京区
- Year and Date
  2012-01-21
- Data Source
  KAKENHI-PROJECT-22790888
[Presentation] ホルモン療法抵抗性前立腺がん細胞におけるエネルギー代謝関連核内受容体作用の検討2012
- Author(s)
  堀江公仁子、高山賢一、伊地知暢広、池田和博、井上聡
- Organizer
  脳心血管抗加齢研究会2012
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-24701033
[Presentation] EBAG9 immunoreactivity is a potential prognostic factor for poor outcome of breast cancer patients with adjuvant tamoxifen therapy2012
- Author(s)
  Shigekawa T, Ijichi N, Ikeda K, Miyazaki T, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S
- Organizer
  35th San Antonio Breast Cancer Symposium, San Antonio
- Place of Presentation
  Texas, USA
- Data Source
  KAKENHI-PROJECT-24701033
[Presentation] フォークヘッド転写因子FOXP1 の全ゲノムにおける結合部位同定による ER シグナル調節機構の解析2012
- Author(s)
  伊地知暢広、堀江公仁子、池田和博、大石貴史、井上聡
- Organizer
  第20回日本ステロイドホルモン学会
- Place of Presentation
  石川
- Year and Date
  2012-11-18
- Data Source
  KAKENHI-PROJECT-24701033
[Presentation] 乳がんならびに子宮内膜がんにおけるフォークヘッド転写因子FOXA1の機能と臨床的意義2011
- Author(s)
  伊地知暢広
- Organizer
  第19回日本ステロイドホルモン学会
- Place of Presentation
  福岡大学(福岡県福岡市)
- Year and Date
  2011-11-26
- Data Source
  KAKENHI-PROJECT-22790888
[Presentation] 乳がんならびに子宮内膜がんにおけるフォークヘッド転写因子FOXA1の機能と臨床的意義2011
- Author(s)
  伊地知暢広、重川崇、阿部弥生、池田和博、堀江公仁子、茅野秀一、津田均、大崎昭彦、竹田省、佐伯俊昭、井上聡
- Organizer
  第19回日本ステロイドホルモン学会
- Place of Presentation
  福岡市
- Year and Date
  2011-11-26
- Data Source
  KAKENHI-PROJECT-22790888
[Presentation] 間葉系由来細胞の脂肪細胞分化におけるエストロゲン関連受容体の機能的役割2010
- Author(s)
  伊地知暢広
- Organizer
  第31回日本肥満学会
- Place of Presentation
  前橋プラザ元気21(前橋)
- Year and Date
  2010-10-01
- Data Source
  KAKENHI-PROJECT-22790888
[Presentation] エストロゲン関連受容体ERRγは乳がんにおける細胞増殖とエストロゲンシグナル経路を調節する2010
- Author(s)
  伊地知暢広
- Organizer
  第28回日本ステロイドホルモン学会
- Place of Presentation
  WINC AICHI(名古屋)
- Year and Date
  2010-11-27
- Data Source
  KAKENHI-PROJECT-22790888

1. Ken-ichiro Kosai (90258418)

# of Collaborated Projects: 9 results

# of Collaborated Products: 27 results
2. MITSUI Kaoru (40324975)

# of Collaborated Projects: 6 results

# of Collaborated Products: 6 results
3. IRIE Rie (90381178)

# of Collaborated Projects: 5 results

# of Collaborated Products: 0 results
4. WAN Yu-chin (20505143)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
5. 永野聡 (50373139)

# of Collaborated Projects: 2 results

# of Collaborated Products: 5 results
6. 近藤亨 (30270573)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 井上聰

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
8. 池田和博

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. 前薗理恵

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results

IJICHI Nobuhiro 伊地知 暢広

Research Projects

Research Products

Co-Researchers

多面的な抗腫瘍免疫誘導をもたらす革新的ながん免疫ウイルス併用療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Generation of Innovative Cancer Immune Gene and Cell Therapy Technology by Replicating Virus and CAR-T

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

a

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of innovative immunovirotherapy facilitating anti-tumor immunity in bone and soft tissue tumorsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of Innovative Gene-Virus Therapy for Tumor Lysis, Immunity Induction, and Cancer Stem Cell Suppression in Bone and Soft Tissue Sarcoma.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of the novel oncolytic immuno-virotherapy for bone and soft tissue tumorsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Molecular elucidation of normal and cancer stem cells towards development of innovative m-CRA therapy for pediatric cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of the novel vector system targeting and identifying cancer stem cells for innovative cancer therapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The development of the novel vector that eliminates ES/iPS cell-derived tumor to realize regenerative medicine

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Identificationof novel diagnostic and therapeutic factors for endocrine therapy-resistant breast cancer by next-generation sequencing strategyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

A novel method for identification and isolation of human pluripotent stem cell-derived target cells and elimination of tumorigenic cells.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Evaluation of functional roles of estrogen related receptors(ERRs) on differentiation of mesenchymal-derived cells using induced pluripotent stem cells.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 次世代がん治療研究最前線2017

Author(s)

Publisher

Data Source

IJICHI Nobuhiro 伊地知暢広

[Book] 次世代がん治療第3編ウイルスを用いたがん治療第3章ウイルス治療薬開発『独自開発の多因子増殖制御型アデノウイルス（m-CRA）技術による遺伝子・ウイルス治療薬の臨床開発と実用化の展望』2017